Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Abstractive Health›
Products & Services
AddedJun 13, 2026
UpdatedJul 6, 2026
Clinical Documentation Platform

Abstractive Health› offers Clinical Documentation Platform

Product
Currently Offered

AI physician assistant that retrieves outside medical records and assembles source-cited clinical summaries.

Loading
Overview

The platform retrieves a patient's full longitudinal chart from national health information exchange networks through Carequality and CommonWell connections, then condenses it into an AI medical record summary with sentence-level source links. A retrieval-augmented generation engine layers in research evidence and answers clinical questions over the assembled record.

The summary runs as a SMART on FHIR application inside Epic, Cerner, Athena, eClinicalWorks, and other electronic health records, giving clinicians outside-record context as the first step of care. It operates under HIPAA and SOC 2 Type 2 controls and is offered in free, per-user, and organizational tiers.

Clinical Documentation Platform - Classification

Model
  • AI Platform
Tags
  • Healthtech

Clinical Documentation Platform - Direct Competitors

  • Abridge

    Abridge logo

    Ambient Clinical Documentation

    abridge.com

  • Suki

    Suki logo

    Suki — Ambient Clinical Documentation

    suki.ai

AttributeClinical Documentation PlatformAmbient Clinical DocumentationSuki — Ambient Clinical Documentation
ProviderAbstractive Healthabstractivehealth.com$1.8M raised · Pre-SeedAbridgeabridge.com$757.5M raised · Series E-IISukisuki.ai$95M raised · Series C
Founded202220182016
Sells ToEnterpriseB2B, EnterpriseEnterprise
Pricing ModelRecurring, SoftwareB2B Subscription, Recurring, SoftwareRecurring, Software
OwnershipVenture CapitalVenture CapitalEquity, Venture Capital
Clinical Documentation Platform

Provider Abstractive Healthabstractivehealth.com$1.8M raised · Pre-Seed

Founded 2022

Sells To Enterprise

Pricing Model Recurring, Software

Ownership Venture Capital

Ambient Clinical Documentation

Provider Abridgeabridge.com$757.5M raised · Series E-II

Founded 2018

Sells To B2B, Enterprise

Pricing Model B2B Subscription, Recurring, Software

Ownership Venture Capital

Suki — Ambient Clinical Documentation

Provider Sukisuki.ai$95M raised · Series C

Founded 2016

Sells To Enterprise

Pricing Model Recurring, Software

Ownership Equity, Venture Capital

Similar Products & Services

  • Healthcare Administrative Automation Platform logo

    Healthcare Administrative Automation Platform

  • AI Voice Agent Platform for Healthcare logo

    AI Voice Agent Platform for Healthcare

  • AI Clinical Documentation logo

    AI Clinical Documentation